Overview

Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea

Status:
Completed
Trial end date:
2018-06-30
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multiple-dose, two-sequence, two-period crossover study to to compare the safety/tolerability and pharmacokinetics between Pletaal SR Cap. and Cilostan CR Tab. in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Bundang CHA Hospital